Supportive care in patients with advanced non-small-cell lung cancer. - Wikidata - awgldk - TriplyDB

Supportive care in patients with advanced non-small-cell lung cancer.

Supportive care in patients with advanced non-small-cell lung cancer.

http://www.wikidata.org/entity/Q36648391

about

[A meta analysis of doublets versus single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer].Quality of life as an outcome variable in the management of advanced cancer.Effect of Palliative Drug Therapy on Quality of life in Advanced Head and Neck Cancer Patients.Chemotherapy in elderly patients with advanced lung cancer. Part II: Treatment of non-small cell lung cancer (NSCLC).Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer Retrospective review of cancer patients > or =80 years old treated with chemotherapy at a comprehensive cancer center.Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancer.Use of and spending on supportive care medications among Medicare beneficiaries with cancer.

P2860

Q33401712-B21E9E8E-D59F-4C65-922F-75C409E5F0A0 Q34952222-40B3BFBA-8181-4642-AF8C-A7AC71974E74 Q35113128-DA804290-F76F-4B15-AC4C-24559E861F5B Q35980560-FA2DBE3D-B46A-4048-9569-4BB2E83BB2EF Q36694349-11F77D9D-0E2B-4B2A-9D78-04158D3CB5C0 Q36924356-A1650FE9-4F46-4EFC-8FF0-0DC56FAD90CC Q37119462-4ECC668D-7AFC-4A24-9D06-6698CABC7539 Q37383735-A4910E6D-9754-43C8-B9B5-123646CFE1DD Q45999039-84AF70E1-1313-47B1-93ED-038581CA945F

P2860

Supportive care in patients with advanced non-small-cell lung cancer.

http://www.wikidata.org/entity/Q36648391

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Supportive care in patients with advanced non-small-cell lung cancer.

@ast

Supportive care in patients with advanced non-small-cell lung cancer.

@en

type

label

Supportive care in patients with advanced non-small-cell lung cancer.

@ast

Supportive care in patients with advanced non-small-cell lung cancer.

@en

prefLabel

Supportive care in patients with advanced non-small-cell lung cancer.

@ast

Supportive care in patients with advanced non-small-cell lung cancer.

@en

P1433

Q36648391-58D2AEDF-02EE-4C65-8E99-0E6A098B2717

P1476

Q36648391-E1F54E57-88B6-4E10-91A7-0EC0F74ED952

P2093

Q36648391-00461E30-BD42-4BDB-A540-566A40B36E3A

Q36648391-01E58C39-6A83-45A8-BE30-853E9135DFA9

Q36648391-02065886-AA7C-4DF7-BBB9-342090B4007D

Q36648391-03F55765-6AD9-414A-ACFC-8B6E7E23B6C8

Q36648391-0583B1E6-004A-4672-83DE-28DE26BB5C1D

Q36648391-0A021689-E733-48DA-8F4E-5F45ED170800

Q36648391-0D8F1A16-4E8B-471F-B78A-4907EBCD6A09

Q36648391-10F8DC62-0F2B-4F21-A7F6-FB172BEE6E01

Q36648391-1215EBA1-B47F-4047-AD6E-FA1B194FD1C5

Q36648391-1496627B-2879-4D23-ABE2-97FE48EA6C1A

P2860

Q36648391-02FD6678-D1F8-4249-ABC7-55AD02717656

Q36648391-0F228801-3423-443C-9BDE-06E7F3793C67

Q36648391-1008DFA6-420D-4A13-91B1-EDFFD037E8C6

Q36648391-43AA3DA7-71D4-43EA-9C0F-3E505C14CB39

Q36648391-4571A077-A3C4-4D90-9152-D59D74FADB89

Q36648391-668D0132-D5C5-4AA8-8882-D7D378B9721B

Q36648391-A84E19D5-CFC9-42C8-AB4C-82B4B346CD46

Q36648391-AFC609FD-E890-4040-8526-CDE31396264E

Q36648391-CD8DB354-BBFF-4123-8237-2C834DE548AB

Q36648391-D714F072-61C4-4212-9278-D5D95BD1F045

P2888

Q36648391-85939AEB-BEEB-4C99-A2F3-5CBAC844FD41

P304

Q36648391-9D410BCE-E729-4B38-B558-0726C4706E9F

P31

Q36648391-2708ADD8-ED6E-4D1D-8F4F-300AFC77384E

P356

Q36648391-70E7818A-09BF-411B-B92A-FA3C33B09EB5

P407

Q36648391-90EAFB01-515B-457A-BEB4-2D6D97961F11

P433

Q36648391-5D0CE809-3A99-4BD2-9DFD-2DDC9B6E53F0

P478

Q36648391-3E7453B0-C8CC-4E80-8886-69CCBB317566

P50

Q36648391-48FB1500-D483-48B3-88EA-5439C9984540

Q36648391-50BCDD39-D0FA-44EF-B675-9FB069582C67

Q36648391-5499378E-0F74-41C2-BAA2-1BF8C235FB57

Q36648391-AB42D8A7-8520-48D8-AB57-5E0FA8EF232B

Q36648391-D3BD67ED-B159-473B-9B04-53923493FF3F

P577

Q36648391-936026D0-9CC2-457A-80C2-70AFFD8812DB

P5875

Q36648391-5AC86CA0-F4F4-4DB5-9F3A-0DE29DC5EF15

P698

Q36648391-29D93173-70CC-4A9D-83C5-B72E5FC3B5F7

P932

Q36648391-8F9B6792-CC91-435C-A7C1-08DC7689D037

P356

P1433

British Journal of Cancer

P1476

Supportive care in patients with advanced non-small-cell lung cancer

@en

P2093

A Illiano

http://www.w3.org/2001/XMLSchema#string

Adolfo Favaretto

http://www.w3.org/2001/XMLSchema#string

Alberto Raina

http://www.w3.org/2001/XMLSchema#string

Alessandra Bearz

http://www.w3.org/2001/XMLSchema#string

Alessandra Morabito

http://www.w3.org/2001/XMLSchema#string

Alfredo Celano

http://www.w3.org/2001/XMLSchema#string

Alfredo Lamberti

http://www.w3.org/2001/XMLSchema#string

Angela Dinota

http://www.w3.org/2001/XMLSchema#string

Angela Sibau

http://www.w3.org/2001/XMLSchema#string

Anna Calcagno

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical aspects of the analysis of data from retrospective studies of disease

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Patient-oriented strategies for the prevention of drug interactions.

Drug-related problems: their structure and function.

A case for geriatric oncology.

Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance

Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer.

Drug interactions in the elderly. How multiple drug use increases risk exponentially.

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical T

P2888

P304

1013-1021

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6601236

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P50

Mario Spatafora

Massimo Di Maio

Silvio Monfardini

Giuseppe Altavilla

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232781284

http://www.w3.org/2001/XMLSchema#string

P698

12966418

http://www.w3.org/2001/XMLSchema#string

P932

2376945

http://www.w3.org/2001/XMLSchema#string